Serum from patients with erectile dysfunction inhibits circulating angiogenic cells from healthy men: Relationship with cardiovascular risk, endothelial damage and circulating angiogenic modulators

International Journal of Andrology

Volumn 35, Issue 5, 2012, Pages 645-652

  Pelliccione, F ^a   D'Angeli, A ^a   Filipponi, S ^a   Falone, S ^a   Necozione, S ^a   Barbonetti, A ^a   Francavilla, F ^a   Francavilla, S ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Cardiovascular risk; Circulating angiogenic cells; Endothelial cell damage; Erectile dysfunction

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR; ULEX EUROPAEUS AGGLUTININ; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; B SCAN; CARDIOVASCULAR RISK; CELLS; CIRCULATING ANGIOGENIC CELL; CLINICAL ARTICLE; COLONY FORMING UNIT; COMMON CAROTID ARTERY; DISEASE SEVERITY; ERECTILE DYSFUNCTION; EX VIVO STUDY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; TISSUES;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; E-SELECTIN; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ERECTILE DYSFUNCTION; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; RISK FACTORS; STEM CELLS; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84866182857     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2012.01253.x     Document Type: Article

References (33)

1. Ahmad S & Ahmed A. (2004) Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 95, 884-891.
2. Araujo AB, Hall SA, Ganz P, Chiu GR, Rosen RC, Kupelian V, Travison TG & McKinlay JB. (2010) Does Erectile Dysfunction Contribute to Cardiovascular Disease Risk Prediction beyond the Framingham Risk Score? J Am Coll Cardiol 55, 350-356.
3. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB & Rimm EB. (2003) Sexual function in men older than 50years of age: results from the health professionals follow-up study. Ann Intern Med 139, 161-168.
4. Baumhäkel M, Werner N, Böhm M & Nickenig G. (2006) Circulating endothelial progenitor cells correlate with erectile function in patients with coronary heart disease. Eur Heart J 27, 2184-2188.
5. Bocchio M, Desideri G, Scarpelli P, Necozione S, Properzi G, Spartera C, Francavilla F, Ferri C & Francavilla S. (2004) Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage. J Urol 171, 1601-1604.
6. Bocchio M, Scarpelli P, Necozione S, Pelliccione F, Mhialca R, Spartera C, Francavilla F & Francavilla S. (2005) Intima media thickening of common carotid arteries is a risk factor for severe erectile dysfunction in men with vascular risk factors but no clinical evidence of atherosclerosis. J Urol 173, 526-529.
7. Bocchio M, Pelliccione F, Passaquale G, Mihalca R, Necozione S, Desideri G, Francavilla F, Ferri C & Francavilla S. (2008) Inhibition of phosphodiesterase type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with cardiovascular risk factors and erectile dysfunction. Atherosclerosis 196, 313-319, Epub 2006 Dec 5.
8. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G & Barnes RW. (1995) Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerotic Risk in Communities (ARIC) Study. Stroke 26, 386-391.
9. Chambless LE, Folsom AR, Davis V, Sharrett R, Heiss G & Sorlie P. (2002) Risk factors for progression of common carotid atherosclerosis: The Atherosclerotic Risk in Communities Study, 1987-1998. Am J Epidemiol 155, 38-47.
10. Chong AY, Blann AD & Lip GYH. (2003) Assessment of endothelial damage and dysfunction: observations in relation to heart failure. Q J Med 96, 253-267.
11. De Groot K, Bahlmann FH, Sowa J, Koenig J, Menne J, Haller H & Fliser D. (2004) Uremia causes endothelial progenitor cell deficiency. Kidney Int 66, 641-646.
12. Deanfield JE, Halcox JP & Rabelink TJ. (2007) Endothelial Function and Dysfunction: testing and Clinical Relevance. Circulation 115, 1285-1295.
13. Esposito K, Ciotola M, Maiorino MI, Giugliano F, Autorino R, De Sio M, Jannini E, Lenzi A & Giugliano D. (2009) Circulating CD34+ KDR+ endothelial progenitor cells correlate with erectile function and endothlial function in overweight men. J Sex Med 6, 107-114.
14. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). (2007) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486-2497.
15. Feinbloom D & Bauer KA. (2005) Assessment of haemostatic risk factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol 25, 2043-2053.
16. Foresta C, Caretta N, Lana A, Cabrelle A, Palu G & Ferlin A. (2005) Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int J Impot Res 17, 288-290.
17. Francavilla S, Properzi G, Bellini C, Marino G, Ferri C & Santucci A. (1997) Endothelin-1 in diabetic and nondiabetic men with erectile dysfunction. J Urol 158, 1770-1774.
18. Henrich D, Hahn P, Wahl M, Wilhelm K, Dernbach E, Dimmeler S & Marzi I. (2004) Serum derived from multiple trauma patients promotes the differentiation of endothelial progenitor cells in vitro: possible role of transforming growth factor-beta1 and vascular endothelial growth factor165. Shock 21, 13-16.
19. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA & Finkel T. (2003) Circulating endothelial progenitor cells vascular function, and cardiovascular risk. N Engl J Med 348, 593-600.
20. Hwang S-J, Christie M, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr & Boerwinkle E. (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation 96, 4219-4225.
21. Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM, Roger VL & Jacobsen S. (2009) A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 84, 108-113.
22. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM & Asahara T. (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97, 3422-3427.
23. Kerbel RS. (2008) Tumor angiogenesis. N Engl J Med 358, 2039-2049.
24. La Vignera S, Condorelli R, Vicari E, D'Agata R & Calogero A. (2011) Circulating endothelial progenitor cells and endothelial microparticles in patients with arterial erectile dysfunction and metabolic syndrome. J Androl ???, ???-??? [Epub ahead of print].
25. Rehman J, Li J, Orschell CM & March KL. (2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107, 1164-1169.
26. Rosen RC, Cappelleri JC, Smith MD, Lipsky J & Pena BM. (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11, 319-326.
27. Sarnak MJ, Levey AS & Schoolwerth AC. (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108, 2154-2169.
28. Thompson IM, Tangen CM, Goodman PJ, Probstifield JL, Moinpour CM & Coltman CA. (2005) Erectile dysfunction and subsequent cardiovascular disease. JAMA 294, 2996-3002.
29. Timmermans F, Plum J, Yöder MC, Ingram DA, Vandekerckhove B & Case J. (2009) Endothelial progenitor cells: identity defined? J Cell Mol Med 13, 87-102.
30. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM & Dimmeler S. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89, E1-E7.
31. Vlachopoulos C, Aznaouridis K, Ioakeimidis N, Rokkas K, Vasiliadou C, Alexopoulos N, Stefanadi E, Askitis A & Stefanadis C. (2006) Unfavorable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J 27, 2640-2648.
32. Wu FT, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH & Popel AS. (2010) A system biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J Cell Mol Med 14, 528-552.
33. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT & Ingram DA. (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109, 1801-1809.